These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28600554)

  • 1. Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasis.
    Carvalho AM; Fukutani KF; Sharma R; Curvelo RP; Miranda JC; Barral A; Carvalho EM; Valenzuela JG; Oliveira F; de Oliveira CI
    Sci Rep; 2017 Jun; 7(1):3149. PubMed ID: 28600554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection.
    Gomes R; Cavalcanti K; Teixeira C; Carvalho AM; Mattos PS; Cristal JR; Muniz AC; Miranda JC; de Oliveira CI; Barral A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005078. PubMed ID: 27812113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.
    Carvalho AM; Viana SM; Andrade BB; Oliveira F; Valenzuela JG; Carvalho EM; de Oliveira CI
    Clin Infect Dis; 2022 Nov; 75(10):1754-1762. PubMed ID: 35385578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection.
    de Moura TR; Oliveira F; Carneiro MW; Miranda JC; Clarêncio J; Barral-Netto M; Brodskyn C; Barral A; Ribeiro JM; Valenzuela JG; de Oliveira CI
    PLoS Negl Trop Dis; 2013; 7(5):e2242. PubMed ID: 23717705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia.
    Tavares NM; Silva RA; Costa DJ; Pitombo MA; Fukutani KF; Miranda JC; Valenzuela JG; Barral A; de Oliveira CI; Barral-Netto M; Brodskyn C
    PLoS Negl Trop Dis; 2011; 5(5):e1169. PubMed ID: 21655303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.
    Carvalho AM; Cristal JR; Muniz AC; Carvalho LP; Gomes R; Miranda JC; Barral A; Carvalho EM; de Oliveira CI
    J Infect Dis; 2015 Jul; 212(1):157-65. PubMed ID: 25596303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with LJM11 salivary protein protects against infection with Leishmania braziliensis in the presence of Lutzomyia longipalpis saliva.
    Cunha JM; Abbehusen M; Suarez M; Valenzuela J; Teixeira CR; Brodskyn CI
    Acta Trop; 2018 Jan; 177():164-170. PubMed ID: 29037520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Lutzomyia longipalpis Salivary Protein Induces Cross-Reactive Antibodies to Pemphigus Autoantigen Desmoglein 1.
    Diaz LA; Prisayanh P; Qaqish B; Temple BR; Aoki V; Hans-Filho G; Rivitti EA; Friedman H; Karetnick M; Herbert SM; Valenzuela JG;
    J Invest Dermatol; 2020 Dec; 140(12):2332-2342.e10. PubMed ID: 32360599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis.
    Vinhas V; Andrade BB; Paes F; Bomura A; Clarencio J; Miranda JC; Báfica A; Barral A; Barral-Netto M
    Eur J Immunol; 2007 Nov; 37(11):3111-21. PubMed ID: 17935072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic diversity in maxadilan, a salivary protein from the sand fly vector of American visceral leishmaniasis.
    Milleron RS; Mutebi JP; Valle S; Montoya A; Yin H; Soong L; Lanzaro GC
    Am J Trop Med Hyg; 2004 Mar; 70(3):286-93. PubMed ID: 15031518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America.
    Teixeira C; Gomes R; Collin N; Reynoso D; Jochim R; Oliveira F; Seitz A; Elnaiem DE; Caldas A; de Souza AP; Brodskyn CI; de Oliveira CI; Mendonca I; Costa CH; Volf P; Barral A; Kamhawi S; Valenzuela JG
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e638. PubMed ID: 20351786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas.
    Souza AP; Andrade BB; Aquino D; Entringer P; Miranda JC; Alcantara R; Ruiz D; Soto M; Teixeira CR; Valenzuela JG; de Oliveira CI; Brodskyn CI; Barral-Netto M; Barral A
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e649. PubMed ID: 20351785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania.
    Collin N; Gomes R; Teixeira C; Cheng L; Laughinghouse A; Ward JM; Elnaiem DE; Fischer L; Valenzuela JG; Kamhawi S
    PLoS Pathog; 2009 May; 5(5):e1000441. PubMed ID: 19461875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The salivary glands of two sand fly vectors of Leishmania: Lutzomyia migonei (França) and Lutzomyia ovallesi (Ortiz)(Diptera: Psychodidae).
    Nieves E; Buelvas N; Rondón M; González N
    Biomedica; 2010; 30(3):401-9. PubMed ID: 21713342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immune response to sand fly salivary gland antigens: a useful epidemiological marker?
    Barral A; Honda E; Caldas A; Costa J; Vinhas V; Rowton ED; Valenzuela JG; Charlab R; Barral-Netto M; Ribeiro JM
    Am J Trop Med Hyg; 2000 Jun; 62(6):740-5. PubMed ID: 11304066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of naturally infected Lutzomyia intermedia and Lutzomyia migonei with Leishmania (Viannia) braziliensis in Rio de Janeiro (Brazil) revealed by a PCR multiplex non-isotopic hybridisation assay.
    de Pita-Pereira D; Alves CR; Souza MB; Brazil RP; Bertho AL; de Figueiredo Barbosa A; Britto CC
    Trans R Soc Trop Med Hyg; 2005 Dec; 99(12):905-13. PubMed ID: 16143358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.
    Gomes R; Teixeira C; Teixeira MJ; Oliveira F; Menezes MJ; Silva C; de Oliveira CI; Miranda JC; Elnaiem DE; Kamhawi S; Valenzuela JG; Brodskyn CI
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7845-50. PubMed ID: 18509051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated exposure to Lutzomyia intermedia sand fly saliva induces local expression of interferon-inducible genes both at the site of injection in mice and in human blood.
    Weinkopff T; de Oliveira CI; de Carvalho AM; Hauyon-La Torre Y; Muniz AC; Miranda JC; Barral A; Tacchini-Cottier F
    PLoS Negl Trop Dis; 2014; 8(1):e2627. PubMed ID: 24421912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maxadilan-simile expression in Nyssomyia neivai, a sandfly vector in an endemic region of Brazil, and its immunogenicity in patients with American tegumentary leishmaniasis.
    Aires J; Casanova C; Vernal S; Nascimento M; Rodrigues S; Lerner EA; Roselino AM
    Mem Inst Oswaldo Cruz; 2017 Feb; 112(2):116-122. PubMed ID: 28177045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Recombinant Salivary Protein PpSP32 as a Suitable Marker of Human Exposure to Phlebotomus papatasi, the Vector of Leishmania major in Tunisia.
    Marzouki S; Kammoun-Rebai W; Bettaieb J; Abdeladhim M; Hadj Kacem S; Abdelkader R; Gritli S; Chemkhi J; Aslan H; Kamhawi S; Ben Salah A; Louzir H; Valenzuela JG; Ben Ahmed M
    PLoS Negl Trop Dis; 2015; 9(9):e0003991. PubMed ID: 26368935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.